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Introduction {#sec1-1}
============

Although the peripheral nerve has remarkable regenerative abilities after injury, it is difficult to recover completely from long-term nerve defects following peripheral nerve injury (PNI) (Raimondo et al., 2011). After PNI, Wallerian degeneration, a complicated process involving distal axonal degeneration and myelin breakdown, takes place immediately (Geuna et al., 2009). Subsequently, multiple macrophages and monocytes migrate to remove the axon and myelin debris. Schwann cells proliferate to form bands of Büngner as a bridge to the defective peripheral nerve system. They secrete a large number of chemokines, cytokines and other trophic factors and extracellular matrix molecules, which form a favorable microenvironment for peripheral nerve regeneration (Frostick et al., 1998; Chen et al., 2007). This microenvironment is one of the major factors of regenerative success (Webber and Zochodne, 2010). Therefore, it is important to investigate the key molecules and regulators affecting nerve regeneration after PNI.

In early studies, microarrays were widely used to characterize differentially expressed genes in the distal nerve stump following PNI (Pan et al., 2017). Temporal expression patterns of upregulated and downregulated genes during Wallerian degen-eration were validated (Yu et al., 2016; Yi et al., 2017). RNA-sequencing was also performed to evaluate comprehensive transcriptomic expression and identify numerous differentially expressed microRNAs at different time points during peripheral nerve regeneration (Yi et al., 2015). These studies have helped elucidate global gene expression changes involved in peripheral nerve repair. However, in many cases during peripheral nerve regeneration, multiple cellular events occur after a gene is translated into a protein. Several studies have suggested that some proteins have significant effects on many biological processes during peripheral nerve repair and Wallerian degeneration, including immune responses, macrophage recruitment and Schwann cell reprogramming (van der Laan et al., 1996; da Costa et al., 1997; Siebert et al., 2000; Takahashi et al., 2007; Clements et al., 2017). Nevertheless, the integrated relationships between proteins involved in PNI and recovery are not yet clear.

In this study, we aimed to investigate the dynamic differential expression of 67 cytokines using a protein micro-array to achieve greater insight into the relative pathways or networks during Wallerian degeneration of injured sciatic nerve. We used bioinformatic analyses (protein-protein interaction (PPI) network, Kyoto Encyclopedia of Genes and Genomes Pathway (KEGG) pathway and gene ontology (GO) analysis).

Materials and Methods {#sec1-2}
=====================

Animals {#sec2-1}
-------

In this study, eighty male Sprague-Dawley rats (specific pathogen free level) weighing 200--250 g, aged 7--8 weeks, were obtained from the Experimental Animal Research Center at the Chinese PLA General Hospital, China. The rats were housed in a temperature-controlled environment and fed water and food *ad libitum*. The Institutional Animal Care and Use Committee of the Chinese PLA General Hospital, China approved the experimental procedures (approval No. 2016-x9-07) in September 2016.

Rats were randomly divided into five groups: control and 4 periods post injury. Briefly, rats were anesthetized by intraperitoneal injection of pentobarbital (30 mg/kg; Sigma-Aldrich, St. Louis, MO, USA). The sciatic nerve was exposed via incision on the lateral aspect of the right hind limb and was excised through the middle site of the exposed sciatic nerve (Yu et al., 2012). At 1, 7, 14, and 28 days after nerve transection, the rats were sacrificed by decapitation. The distal nerve stumps were removed and stored at −80°C until further use. As a control, rats in the 0 day group underwent sham surgery of the right sciatic nerves.

Protein microarray analysis {#sec2-2}
---------------------------

Protein samples were extracted from the distal nerve stumps of sciatic nerves of the rats and lysed in radioimmuno-precipitation assay buffer lysis buffer containing a protease inhibitor cocktail (Pulilai, Beijing, China). Subsequently, protein concentrations were determined using the Pierce Bicinchoninic acid assay Kit (Thermo Fisher, Waltham, MA, USA).

Microarray analysis was performed using the Rat Cytokine Array 67 (RayBiotech, Guangzhou, Guangdong Province, China), as described previously (Luck et al., 2017). Briefly, the microarray was incubated with 100 μL sample diluent at room temperature for 30 minutes to block the slides. After removing the diluent, the array was completely covered with 100 μL of the protein sample (2 mg/mL) and incubated at 4°C overnight. Biotinylated antibody cocktail (80 μL) was added to each well at room temperature for 2 hours. Cy3 equivalent dye-conjugated streptavidin (80 μL) was added to each well, and the wells were covered with aluminum foil and placed in a dark room to avoid light exposure at room temperature for 1 hour. The signals were visualized using the LuxScan 10K scanner (CapitaBio, Beijing, China) at 532 nm wavelength.

Bioinformatic analysis {#sec2-3}
----------------------

The expression levels of proteins at 1, 7, 14, and 28 days after sciatic nerve transection were compared with those in the control group. Proteins with an expression fold change \> 2 or \< −2 and adjusted *P*-value \< 0.05 were considered significantly differentially expressed. The differentially expressed proteins, Venn diagram and Principal Component analysis were performed by R packages (<http://www.R-project.org>) named gplots, VennDiagram and scatterplot3d, respectively. The GeneMANIA database (<http://genemania.org>) is a gene and protein analysis tool designed to predict PPIs. The various proteins were mapped using GeneMANIA to evaluate the interactive relationships among them. The PPI networks were then constructed using Cytoscape software (<http://www.cytoscape.org>).

Proteins selected from the PPI networks were systematically analyzed using the Database for Annotation, Visu-alization and Integrated Discovery (DAVID; <http://www.david.niaid.nih.gov>) program to identify significantly enriched KEGG pathways and GO categories (Dennis et al., 2003). The KEGG pathways and GO categories were performed by R packages named ggplot2.

Western blot analysis {#sec2-4}
---------------------

Sciatic nerves were rinsed in cold PBS and lysed on ice in radioimmunoprecipitation assay buffer containing a pro-tease inhibitor cocktail (Pulilai), and the resulting tissue lysates were mixed with sample buffer and boiled at 95°C for 5 minutes. Equal amounts of protein from each sample were subjected to 10--15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes (Pulilai). The membranes were blocked in 5% nonfat dry milk at 4°C for 1 hour and incubated with rabbit anti-hepatocyte growth factor (HGF) antibody (1:1000; ab83760, Abcam, Cambridge, UK), rabbit anti-glial cell line-derived neurotrophic factor (GDNF) antibody (1:1000; ab18956, Abcam), rabbit anti-ciliary neurotrophic factor (CNTF) antibody (1:1000; ab46172, Abcam) or rabbit anti-β-actin antibody (1:1000; Proteintech, Chicago, IL, USA) at 4°C overnight. These were followed by the appropriate secondary antibody, donkey-anti-rabbit-HRP (1:5000, Pulilai) at room temperature for 1 hour. The membranes were developed using an enhanced chemiluminescence substrate (Thermo Fisher). Measurement of the protein band intensities was conducted using ImageJ software (National Institutes of Health, Bethesda, MD, USA).

Statistical analysis {#sec2-5}
--------------------

All data are expressed as the mean ± standard error of the mean (SEM). Significant differences among data were determined by one-way analysis of variance, followed by Tukey's *post hoc* test. All analyses were performed using GraphPad Prism 7.0 (GraphPad Software, Inc., San Diego, CA, USA) and a P-value \< 0.05 was designated as indicating statistical significance.

Results {#sec1-3}
=======

Differentially expressed proteins in the distal nerve stump following sciatic nerve transection {#sec2-6}
-----------------------------------------------------------------------------------------------

To gain a better understanding of the microenvironment of the distal nerve stump, we examined the expression patterns of 67 proteins in injured sciatic nerves at different time points using the Rat Cytokine Array 67 (**[Table 1](#T1){ref-type="table"}**). Proteins with a fold change in expression \> 2 or \< −2 and an adjusted *P* \< 0.05 were defined as differentially expressed. A full list of the differentially expressed proteins at each time point evaluated is displayed in a heatmap (**Figure [1A](#F1){ref-type="fig"}--[D](#F1){ref-type="fig"}**). Compared with the control group (0 day after PNI), the expression of nearly 20% of the total proteins increased at 1 day after PNI, including some chemokines and interleukins (ILs). The number of upregulated proteins increased to 33% of the total proteins at 7 days after PNI. In addition to chemokines and ILs, Notch 1/2 and Neuropilin 1/2, which are related to some classical pathways, increased in expression starting at 7 days after PNI. At 14 days after PNI, no ILs, except for IL-22, showed any remarkable expression changes. At 28 days after PNI, the number of upregulated proteins had decreased slightly. From day 1 to day 28 after PNI, only a few proteins, including CNTF, were downregulated. The numbers of overlapping differentially expressed proteins at 1, 7, 14, 28 days post injury are displayed in a Venn diagram (**[Figure 1E](#F1){ref-type="fig"}**). Principal component analysis based on the expression values of the 67 proteins demonstrated five completely independent clusters: control and the other time points after injury (**[Figure 1F](#F1){ref-type="fig"}**).

###### 

The 67 cytokine proteins included on the RayBiotech Rat Cytokine Array 67

  Proteins      Genes      Proteins   Genes         Proteins       Genes       Proteins         Genes
  ------------- ---------- ---------- ------------- -------------- ----------- ---------------- ----------
  CD48          *Cd48*     IL-10      *Il10*        CNTF           *Cntf*      Adiponectin      *Adipoq*
  B7-1          *Cd80*     IL-13      *Il13*        FGF-BP         *Fgfbp1*    RAGE             *Ager*
  B7-2          *Cd86*     IL-17F     *Il17f*       GFR alpha-1    *Gfra1*     GM-CSF           *Csf2*
  P-Cadherin    *Cdh3*     IL-1a      *Il1a*        HGF            *Hgf*       Decorin          *Dcn*
  Eotaxin       *Ccl11*    IL-1b      *Il1b*        IFNg           *Ifng*      EphA5            *Epha5*
  MCP-1         *Ccl2*     IL-1 R6    *Il1rl2*      b-NGF          *Ngf*       Erythropoietin   *Epo*
  CTACK         *Ccl27*    IL-1 ra    *Il1rn*       PDGF-AA        *Pdgfa*     JAM-A            *F11r*
  MIP-1a        *Ccl3*     IL-2       *Il2*         TNFa           *Tnf*       Gas 1            *Gas1*
  RANTES        *Ccl5*     IL-22      *Il22*        VEGFA          *Vegfa*     TIM-1            *Havcr1*
  Fractalkine   *Cx3cl1*   IL-2 Ra    *Il2ra*       4-1BB          *Tnfrsf9*   ICAM-1           *Icam1*
  CINC-1        *Cxcl1*    IL-3       *Il3*         Flt-3L         *Flt3lg*    Nope             *Igdcc4*
  CINC-3        *Cxcl2*    IL-4       *Il4*         Galectin-1     *Lgals1*    Activin A        *Inhba*
  CINC-2        *Cxcl3*    IL-6       *Il6*         Galectin-3     *Lgals3*    SCF              *Kitlg*
  LIX           *Cxcl5*    gp130      *Il6st*       Notch-1        *Notch1*    TCK-1            *Ppbp*
  TIMP-1        *Timp1*    IL-7       *Il7*         Notch-2        *Notch2*    Prolactin        *Prl*
  TIMP-2        *Timp2*    TWEAK R    *Tnfrsf12a*   Neuropilin-1   *Nrp1*      Prolactin R      *Prlr*
                           TREM-1     *Trem1*       Neuropilin-2   *Nrp2*      L-Selectin       *Sell*

![Overview of differentially expressed cytokines at the distal stump following sciatic nerve transection.\
(A--D) Heatmap and hierarchical clustering at 1 (A), 7 (B), 14 (C), 28 (D) days. Protein expression was increased (red) and decreased (green) compared with the control (0 day after sciatic nerve transection). (E) Venn diagram displaying the number of different proteins among the four groups of sciatic nerves at each time point after sciatic nerve transection. (F) Principal component analysis of the differentially expressed cytokines at different time points following sciatic nerve transection. PC: Principal component; PCA: principal component analysis.](NRR-15-503-g002){#F1}

Protein-protein interaction network of the differentially expressed proteins {#sec2-7}
----------------------------------------------------------------------------

Many proteins were temporally differentially expressed in the injured sciatic nerve, suggesting that those cytokines have a dramatic effect on the nerve microenvironment after PNI. To explore this further, PPI networks were constructed by uploading the up- and downregulated proteins into GeneMANIA. In addition to the differentially expressed proteins, other chemotactic and inflammatory factors were selected within these networks, such as CC chemokine ligand (CCL17), chemokine (C-X-C motif) ligand (CXCL13), the tissue inhibitor of metalloproteinases-3 (TIMP3) and others. At 1 day after PNI, the differentially expressed proteins were mainly related to chemotactic family proteins (CCL2, CCL3, CCL7, CCL17, CXCL2, CXCL3, CXCL6, CXCL9, CXCL11 and CXCL13) (**[Figure 2A](#F2){ref-type="fig"}**). At 7 days after PNI, the proteins in the PPI included GFR alpha2, GFR alpha3, GFR alpha4, IL9, IL19, IL20, tyrosine-protein kinase 2 (JAK 2), Jag1, Jag2, TIMP3, TIMP4, VEGFB, GDNF, Neurturin (NRTN) (**[Figure 2B](#F2){ref-type="fig"}**). At 14 days after PNI, CCL1, CCL2, CCL5, CCL7, CCL15, CXCL1, CXCL2, intercellular adhesion molecule 2 (ICAM2), ICAM4, ICAM5, GFR alpha1, GDNF family receptor (GFR) alpha2, GFR alpha4, Notch-3, Galectin-1, Galectin-2, Galectin-5, Galectin-12 were selected in the PPI network (**[Figure 2C](#F2){ref-type="fig"}**). At 28 days after PNI, GFR alpha2, GFR alpha3, GFR alpha4, Notch-3, VEGFB, GDNF, NRTN, placenta growth factor, TIMP2, TIMP3, TIMP4, ICAM1, ICAM2, ICAM4, ICAM5, Galectin-12, GTPase Hras, Jag2 interacted with the differentially expressed proteins (**[Figure 2D](#F2){ref-type="fig"}**). In addition, there were several connections between the differentially expressed proteins and the selected proteins. Co-expression characteristics and described physical interactions accounted for most of the aforementioned targets and their interacting proteins. Other results, including shared protein domains, co-localization and predictions are shown in **[Figure 2](#F2){ref-type="fig"}**.

![Networks of protein-protein interactions of the differentially expressed proteins in the distal nerve stump following sciatic nerve transection.\
(A--D) Differentially expressed proteins at 1 (A), 7 (B), 14 (C), 28 (D) days. The sizes of the spots in the network represent the weights of the interaction involving the protein. The red spots represent the upregulated proteins and green spots the downregulated proteins at each time point after sciatic nerve transection. The blue spots represent the selected proteins interact with the differentially expressed proteins. The colors of the the connecting lines represent the different interactions between protein and protein. The thickness of the connecting lines represents the score of each connection.](NRR-15-503-g003){#F2}

Kyoto Encyclopedia of Genes and Genomes enriched analysis of integrated metabolic pathways following sciatic nerve injury {#sec2-8}
-------------------------------------------------------------------------------------------------------------------------

The proteins from the PPI networks were correlated with integrated metabolic pathways using KEGG analysis in DAVID. The top 10 canonical pathways associated with differentially expressed cytokines at each time point were displayed and analyzed using a *P*-value threshold of 0.05 (**[Figure 3](#F3){ref-type="fig"}**). Cytokine-cytokine receptor interactions and rheumatiod arthritis were activated throughout the entire post-injury period. Notably, the chemokine signaling pathways, Janus kinase/signal transducers and activators of transcription (JAK/STAT) and phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), and leishmainasis were drastically stimulated at 1--7 days after PNI, while the notch signaling pathway and dorso-ventral axis formation were enriched at 14--28 days after PNI. Besides, malaria and influenze A were activited at 1--14 days after PNI. A full list of the canonical pathways and their involved molecules identified at 1, 7, 14, and 28 days after PNI is provided in **[Additional Table 1](#T2){ref-type="table"}**.

![Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched among the proteins in the protein-protein interaction network in the distal nerve stump following sciatic nerve transection.\
(A--D) Differentially expressed proteins at 1 (A), 7 (B), 14 (C) and 28 (D) days. The top 10 KEGG pathways with *P* \< 0.05 are listed. The x-axis represents the gene ratio, defined as the ratio of the numbers of differentially expressed proteins to all proteins annotated in the KEGG pathway using Database for Annotation, Visualization, and Integrated Discovery (DAVID; <http://www.david.niaid.nih.gov>).](NRR-15-503-g004){#F3}

###### 

Additional Table 1

  Category            Term                                                 Count   \%             *P*-value    Molecules                                                                                  List total   Pop hits   Pop total   Fold enrichmen   Bonferroni    Benjamini    FDR
  ------------------- ---------------------------------------------------- ------- -------------- ------------ ------------------------------------------------------------------------------------------ ------------ ---------- ----------- ---------------- ------------- ------------ ------------
  **Day 1**                                                                                                                                                                                                                                                                               
  KEGG_PATHWA Y       ssc04060:Cytokine- cytokine receptor interaction     13      0.33121019     3.40E-13     VEGFB, IL4, CCL2, PPBP, IL6ST, TNFRSF12A, CXCL13, VEGFA, CXCL9, NGFR, CXCL11, IL10,        23           221        7030        17.97953964      2.04E-11      2.04E-11     3.40E-10
  KEGG_PATHWA Y       ssc04062:Chemokine signaling pathway                 9       0.22929936     2.73E-08     CCL2,PPBP, CXCL13, CXCL2, CXCL9, JAK2, CXCL11, CCL17, CXCL10                               23           173        7030        15.90098015      1.64E-06      8.18E-07     2.73E-05
  KEGG_PATHWA Y       ssc04630:Jak-STAT signaling pathway                  6       0.15286624     5.85E-05     IL4, IL6ST, IL19, JAK2, IL10, IL20                                                         23           140        7030        13.09937888      0.003500988   0.00116836   0.05856165
  KEGG_PATHWA Y       ssc04151:PI3K-Akt signaling pathway                  6       0.15286624     0.00285045   IL4, VEGFB, PGF, VEGFA, JAK2, NGFR                                                         23           326        7030        5.625500133      0.157406886   0.04191404   2.820171
  KEGG_PATHWA Y       ssc04668:TNF signaling pathway                       4       0.10191083     0.00439045   ICAM1, CCL2, CXCL2, CXCL10                                                                 23           108        7030        11.32045089      0.232031866   0.05143163   4.31383707
  KEGG_PATHWA         ssc05144:Malaria                                     3       0.07643312     0.01127811   ICAM1, CCL2, IL10                                                                          23           52         7030        17.63377926      0.493652212   0.1072261    10.7445415
  KEGG_PATHWA         ssc05164:Influenza A                                 4       0.10191083     0.0145511    ICAM1, CCL2, JAK2, CXCL10                                                                  23           167        7030        7.321010154      0.585001467   0.11806775   13.6617584
  KEGG_PATHWA         ssc05140:Leishmanias                                 3       0.07643312     0.01578332   IL4, JAK2, IL10                                                                            23           62         7030        14.78962132      0.615015566   0.11247541   14.7376045
  KEGG_PATHWA Y       ssc04015:Rap1 signaling pathway                      4       0.10191083     0.02533146   VEGFB, PGF, VEGFA, NGFR                                                                    23           206        7030        5.934993668      0.785505085   0.15722237   22.6735405
  KEGG_PATHWA Y       ssc05323:Rheumatoid arthritis                        3       0.07643312     0.02916058   ICAM1, CCL2, VEGFA                                                                         23           86         7030        10.66228514      0.830627048   0.16269361   25.6646135
  KEGG_PATHWA Y       ssc04014:Ras signaling pathway                       4       0.10191083     0.03002464   VEGFB, PGF, VEGFA, NGFR                                                                    23           220        7030        5.557312253      0.8394382     0.15319063   26.3249811
  KEGG_PATHWA Y       ssc04620:Toll-like receptor signaling pathway        3       0.07643312     0.03917298   CXCL9, CXCL11, CXCL10                                                                      23           101        7030        9.078777443      0.909068921   0.18110913   32.9997956
  KEGG_PATHWA         ssc05310:Asthma                                      2       0.05095541     0.06965828   IL4, IL10                                                                                  23           23         7030        26.57844991      0.986861379   0.28340618   51.4995559
  **Day 7**                                                                                                                                                                                                                                                                               
  KEGG_PATHWA Y       ssc04060:Cytokine- cytokine receptor interaction     14      0.20548951     2.8045E-13   IL4, CCL2, IL7, TNFRSF12A, IL6ST, IL9, CCL5, CCL27, IL10, VEGFB, CNTF, PPBP, VEGFA, IFNG   28           221        7030        15.90497738      2.04723E-11   2.0472E-11   2.9272E-10
  KEGG_PATHWA Y       ssc04630:Jak-STAT signaling pathway                  10      0.14677822     1.3162E-09   IL4, CNTF, IL6ST, IL7, IFNG, IL19, IL9, JAK2, IL10, IL20                                   28           140        7030        17.93367347      9.60815E-08   4.8041E-08   1.3738E-06
  KEGG_PATHWA Y       ssc05323:Rheumatoid arthritis                        5       0.07338911     0.00029559   ICAM1, CCL2, IFNG, VEGFA, CCL5                                                             28           86         7030        14.59717608      0.021350158   0.00716798   0.30810644
  KEGG_PATHWA         ssc05144:Malaria                                     4       0.05871129     0.00098511   ICAM1, CCL2, IFNG, IL10                                                                    28           52         7030        19.31318681      0.06942148    0.0178264    1.02348937
  KEGG_PATHWA         ssc05140:Leishmanias                                 4       0.05871129     0.00164329   IL4, IFNG, JAK2, IL10                                                                      28           62         7030        16.19815668      0.113131722   0.02372577   1.70201483
  KEGG_PATHWA         ssc05310:Asthma                                      3       0.04403347     0.00341977   IL4, IL9, IL10                                                                             28           23         7030        32.7484472       0.221254387   0.04082187   3.51247659
  KEGG_PATHWA         ssc05164:Influenza A                                 5       0.07338911     0.00351799   ICAM1, CCL2, IFNG, JAK2, CCL5                                                              28           167        7030        7.51710864       0.226837364   0.0360851    3.61169015
  KEGG_PATHWA Y       ssc04062:Chemokine signaling pathway                 5       0.07338911     0.00399326   CCL2, PPBP, JAK2, CCL5, CCL27                                                              28           173        7030        7.25639967       0.253300018   0.03585297   4.0904725
  KEGG_PATHWA Y       ssc04151:PI3K-Akt signaling pathway                  6       0.08806693     0.00722646   IL4, VEGFB, PGF, IL7, VEGFA, JAK2                                                          28           326        7030        4.620946538      0.411069421   0.05713054   7.29086559
  KEGG_PATHWA Y       ssc05143:African trypanosomiasis                     3       0.04403347     0.00738845   ICAM1, IFNG, IL10                                                                          28           34         7030        22.15336134      0.418043509   0.0526967    7.44864556
  KEGG_PATHWA Y       ssc05142:Chagas disease (American trypanosomiasis)   4       0.05871129     0.00768878   CCL2, IFNG, CCL5, ILIO                                                                     28           107        7030        9.385847797      0.430758015   0.04993293   7.74051304
  KEGG_PATHWA Y       sscO5330:Allograft rejection                         3       0.04403347     0.00870947   IL4, IFNG, IL10                                                                            28           37         7030        20.35714286      0.471956101   0.05182354   8.72625592
  KEGG_PATHWA Y       SSC04330:Notch signaling pathway                     3       0.04403347     0.0121687    NOTCH2, JAG2, JAG1                                                                         28           44         7030        17.11850649      0.590887078   0.06644097   11.9966412
  KEGG_PATHWA Y       ssc05321:Inflammator y bowel disease (IBD)           3       0.04403347     0.02261767   IL4, IFNG, IL10                                                                            28           61         7030        12.34777518      0.811761955   0.11244886   21.2421676
  KEGG_PATHWA Y       ssc05168:Herpes simplex infection                    4       0.05871129     0.03164347   CCL2, IFNG, JAK2, CCL5                                                                     28           182        7030        5.518053375      0.904374051   0.14485771   28.5113284
  KEGG_PATHWA Y       ssc04066:HIF-1 signaling pathway                     3       0.04403347     0.05684533   IFNG, VEGFA, TIMP1                                                                         28           101        7030        7.457567185      0.986050678   0.23434245   45.7127052
  KEGG_PATHWA Y       ssc04660:T cell receptor signaling pathway           3       0.04403347     0.06191833   IL4, IFNG, IL10                                                                            28           106        7030        7.105795148      0.990590483   0.24002715   48.684362
  KEGG_PATHWA Y       ssc04668:TNF signaling pathway                       3       0.04403347     0.0639902    ICAM1, CCL2, CCL5                                                                          28           108        7030        6.974206349      0.991993018   0.23523844   49.8551108
  KEGG_PATHWAY        ssc05145:Toxoplasmo sis                              3       0.04403347     0.07034613   IFNG, JAK2, IL10                                                                           28           114        7030        6.607142857      0.995130845   0.24440856   53.2975516
  KEGG_PATHWA         ssc05162:Measles                                     3       0.04403347     0.09057419   IL4, IFNG, JAK2                                                                            28           132        7030        5.706168831      0.999022737   0.29286788   62.8793488
  **Day 14**                                                                                                                                                                                                                                                                              
  KEGG_PATHWA Y       rno04062:Chemokine signaling pathway                 7       0.16252612     1.88E-06     CXCL1, CCL1, CCL12, CCL2, CXCL2, CCL5, CCL7                                                19           177        7780        16.19387452      7.92E-05      7.92E-05     1.74E-03
  KEGG_PATHWA Y       rno04668:TNF signaling pathway                       6       0.1393081      3.65E-06     CXCL1, ICAM1, CCL12, CCL2, CXCL2, CCL5                                                     19           109        7780        22.53983583      1.53E-04      7.66E-05     3.38E-03
  KEGG_PATHWA Y       rno04060: Cytokine- cytokine receptor interaction    7       0.16252612     6.00E-06     CCL12, CCL2, CNTF, VEGFA, CCL5, IL22, CCL7                                                 19           216        7780        13.26998051      2.52E-04      8.40E-05     5.55E-03
  KEGG_PATHWA Y       rno05323:Rheumatoid arthritis                        5       0.11609009     4.53E-05     ICAM1, CCL12, CCL2, VEGFA, CCL5                                                            19           90         7780        22.74853801      1.90E-03      4.75E-04     4.19E-02
  KEGG_PATHWA Y       rno05206:MicroRNAs                                   5       0.11609009     2.74E-04     NOTCH3, NOTCH2, NOTCH1, VEGFA,                                                             19           143        7780        14.31726169      1.14E-02      2.30E-03     2.53E-01
  in cancer                                                                                       TIMP3                                                                                                                                                                                   
  KEGG_PATHWA Y       rno04320:Dorso- ventral axis formation               3       0.06965405     1.47E-03     NOTCH3, NOTCH2, NOTCH1                                                                     19           25         7780        49.13684211      5.99E-02      1.02E-02     1.35E+00
  KEGG_PATHWA Y       rno04330:Notch                                       3       0.06965405     6.26E-03     NOTCH3, NOTCH2, NOTCH1                                                                     19           52         7780        23.62348178      2.32E-01      3.70E-02     5.65E+00
  signaling pathway                                                                                                                                                                                                                                                                       
  KEGG_PATHWA         rno05164:Influenza A                                 4       0.09287207     6.68E-03     ICAM1, CCL12, CCL2, CCL5                                                                   19           171        7780        9.578331794      2.45E-01      3.46E-02     6.01E+00
  KEGG_PATHWA Y       rno04621:NOD-like receptor signaling pathway         3       0.06965405     7.23E-03     CCL12, CCL2, CCL5                                                                          19           56         7780        21.93609023      2.63E-01      3.33E-02     6.50E+00
  KEGG_PATHWA         rno05144:Malaria                                     3       0.06965405     8.00E-03     ICAM1, CCL12, CCL2                                                                         19           59         7780        20.82069581      2.86E-01      3.32E-02     7.17E+00
  KEGG_PATHWA Y       rno05142:Chagas disease (American trypanosomiasis)   3       0.06965405     2.48E-02     CCL12, CCL2, CCL5                                                                          19           107        7780        11.48057059      6.52E-01      9.16E-02     2.08E+01
  KEGG_PATHWA Y       rno04919:Thyroid hormone signaling pathway           3       0.06965405     2.84E-02     NOTCH3, NOTCH2, NOTCH1                                                                     19           115        7780        10.6819222       7.02E-01      9.59E-02     2.34E+01
  KEGG_PATHWA Y       rno04514:Cell adhesion molecules                     3       0.06965405     5.90E-02     ICAM1, F11R, ICAM2                                                                         19           172        7780        7.141982864      9.22E-01      1.78E-01     4.30E+01
  KEGG_PATHWA Y       rno05168:Herpes simplex infection                    3       0.06965405     8.78E-02     CCL12, CCL2, CCL5                                                                          19           216        7780        5.687134503      9.79E-01      2.41E-01     5.73E+01
  **Day 28**                                                                                                                                                                                                                                                                              
  KEGG_PATHWA Y       cfa04330:Notch signaling pathway                     5       0.10957703     3.4697E-06   NOTCH3, NOTCH2, NOTCH1, JAG2,                                                              17           47         6781        42.43429287      2.64E-04      0.00026366   3.65E-03
                                                                                   JAG1                                                                                                                                                                                                   
  KEGG_PATHWA Y       cfa05206:MicroRNAs in cancer                         6       0.13149244     1.2266E-05   NOTCH3, NOTCH2, NOTCH1, HRAS,                                                              17           139        6781        17.21794329      9.32E-04      0.000466     1.29E-02
                                                                                   VEGFA, TIMP3                                                                                                                                                                                           
  KEGG_PATHWA Y       cfa04320:Dorso- ventral axis formation               3       0.06574622     0.0017703    NOTCH3, NOTCH2, NOTCH1                                                                     17           27         6781        44.32026144      1.26E-01      0.04389487   1.85E+00
  KEGG_PATHWA Y       cfa04919:Thyroid hormone signaling pathway           4       0.08766163     0.00215415   NOTCH3, NOTCH2, NOTCH1, HRAS                                                               17           113        6781        14.11972931      1.51E-01      0.04014488   2.24E+00
  KEGG_PATHWA Y       cfa04510:Focal adhesion                              4       0.08766163     0.01170373   VEGFB, HRAS, PGF, VEGFA                                                                    17           207        6781        7.707871554      5.91E-01      0.16384884   1.17E+01
  KEGG_PATHWA Y       cfa04015:Rap1 signaling pathway                      4       0.08766163     0.01170373   VEGFB, HRAS, PGF, VEGFA                                                                    17           207        6781        7.707871554      5.91E-01      0.16384884   1.17E+01
  KEGG_PATHWA Y       cfa04060: Cytokine- cytokine receptor interaction    4       0.08766163     0.01313391   VEGFB, CNTF, VEGFA, CCL5                                                                   17           216        6781        7.38671024       6.34E-01      0.15419378   1.30E+01
  KEGG_PATHWA Y       cfa04014:Ras signaling pathway                       4       0.08766163     0.01346491   VEGFB, HRAS, PGF, VEGFA                                                                    17           218        6781        7.318942256      6.43E-01      0.13686453   1.33E+01
  KEGG_PATHWA Y       cfa05323:Rheumatoid arthritis                        3       0.06574622     0.01553142   ICAM1, VEGFA, CCL5                                                                         17           82         6781        14.59325681      6.96E-01      0.13817783   1.52E+01
  KEGG_PATHWA Y       cfa04650:Natural killer cell mediated cytotoxicity   3       0.06574622     0.02174666   ICAM1, HRAS, ICAM2                                                                         17           98         6781        12.21068427      8.12E-01      0.16944791   2.07E+01
  KEGG_PATHWA Y       cfa04151:PI3K-Akt signaling pathway                  4       0.08766163     0.0420905    VEGFB, HRAS, PGF, VEGFA                                                                    17           337        6781        4.73450864       9.62E-01      0.27878282   3.64E+01
  KEGG_PATHWA Y       cfa05200:Pathways in cancer                          4       0.08766163     0.06126129   VEGFB, HRAS, PGF, VEGFA                                                                    17           392        6781        4.070228091      9.92E-01      0.35388619   4.86E+01
  KEGG_PATHWA Y       cfa05205:Proteoglyca ns in cancer                    3       0.06574622     0.07581922   HRAS, VEGFA, TIMP3                                                                         17           195        6781        6.136651584      9.98E-01      0.39308589   5.64E+01
  KEGG_PATHWA Y       cfa05219:Bladder cancer                              2       0.04383081     0.09257318   HRAS, VEGFA                                                                                17           41         6781        19.45767575      9.99E-01      0.4332909    6.40E+01

Gene ontology analysis of biological processes following sciatic nerve injury {#sec2-9}
-----------------------------------------------------------------------------

To further explore the effects of cytokines following sciatic nerve injury, GO analysis was performed in DAVID to analyze biological processes. The top 10 biological processes (*P* \< 0.05) associated with these proteins are displayed in **[Figure 4](#F4){ref-type="fig"}**. At 1--7 days after PNI, biological processes related to inflammation, the immune response, and cell chemotaxis were activated. At 14 days after PNI, even more cell chemotaxis processes, as well as cell response to IL-1, interferon-gamma were activated, including neutrophil, monocyte, lymphocyte, and eosinophil chemotaxis. At 28 days after PNI, neuronal apoptotic processes, cell-cell adhesion, and cell proliferation were enriched. However, some biological processes were negatively regulated at different time after PNI. For example, the negative regulation of apoptosis first increased at 1--7 days after PNI, and then progressively declined at 14 days after PNI, before increasing again at 28 days after PNI. Membrane protein ectodomain proteolysis was inhibited from 7--28 days after PNI. Catalytic activity reduced at 7 and 28 days after PNI. A full list of the biological processes and involved molecules at 1, 7, 14, and 28 days after PNI is provided in **Additional Table 2**. More information on the highly enriched cellular components associated with PNI associated with the external side of the plasma membrane, extracellular matrix, immunological synapse, and receptor complex are shown in **[Additional Table 3](#T3){ref-type="table"}**.

![Gene ontology (GO) biological processes of those proteins enriched in the protein-protein interaction network in the distal nerve stump following sciatic nerve transection relative to all proteins.\
(A--D) Differentially expressed proteins at 1 (A), 7 (B), 14 (C), 28 (D) days. The top 10 GO biological processes with *P* \< 0.05 are listed. The x-axis represents the gene ratio, defined as the ratio of the numbers of differentially expressed proteins to all proteins annotated in the GO biological processes using Database for Annotation, Visualization, and Integrated Discovery (DAVID; <http://www.david.niaid.nih.gov>).](NRR-15-503-g005){#F4}

###### 

Additional Table 3

  Category           Term                                                Count   \%           *P*-value    Molecules                                                                                                                                          List   total Pop hits   Pop total   Fold enrichmei   Bonferroni   Benjamini    FDR
  ------------------ --------------------------------------------------- ------- ------------ ------------ -------------------------------------------------------------------------------------------------------------------------------------------------- ------ ---------------- ----------- ---------------- ------------ ------------ ------------
  **Day 1**                                                                                                                                                                                                                                                                                                                                  
  GOTERM_CC_DIRECT   GO:0005615\~extracellula r space                    20      0.50955414   5.00E-19     IL4, ICAM1, NRP1, CCL2, LGALS3, PGF, LGALS1, CXCL2, IL19, CXCL9, CXCL11, IL10, IL20, CCL17, TIMP1, CXCL10, VEGFB, PPBP, CXCL13, VEGFA              26     762              12833       12.95477488      1.85E-17     1.85E-17     4.49E-16
  GOTERM_CC_DIRECT   GO:0009897\~external side of plasma membrane        5       0.12738854   7.90E-05     IL4, ICAM1, IL6ST, CXCL9, CXCL10                                                                                                                   26     120              12833       20.56570513      0.00291951   0.00146082   0.07092918
  GOTERM_CC_DIRECT   GO:0001772\~immunologi cal synapse                  2       0.05095541   0.04576193   ICAM1, LGALS3                                                                                                                                      26     24               12833       41.13141026      0.82327447   0.43882313   34.3348902
  GOTERM_CC_DIRECT   GO:0016020\~membrane                                5       0.12738854   0.04595763   VEGFB, PGF, ICAM2, VEGFA,                                                                                                                          26     707              12833       3.49064302       0.8246105    0.35285604   34.4557081
  **Day 7**                                                                                                                                                                                                                                                                                                                                  
  GOTERM_CC_DIRECT   GO:0005615\~extracellula r space                    23      0.3375899    1.4551E-17   IL4, ICAM1, CCL2, NRP1, LGALS3, PGF, IL7, LGALS1, IL9, IL1RN, IL19, TIMP4, TIMP2, CCL5, TIMP3, IL10, IL20, TIMP1, VEGFB, CNTF, PPBP, IFNG, VEGFA   40     762              12833       9.683694226      6.1114E-16   6.1114E-16   1.3467E-14
  GOTERM_CC_DIRECT   GO:0009897\~external side of plasma membrane        5       0.07338911   0.00046445   IL4, ICAM1, IL6ST, IFNG, GFRA3                                                                                                                     40     120              12833       13.36770833      0.01932219   0.00970822   0.42902184
  GOTERM_CC_DIRECT   GO:0005578\~proteinaceo us extracellular matrix     5       0.07338911   0.00087497   LGALS1, TIMP4, TIMP2, TIMP3, TIMP1                                                                                                                 40     142              12833       11.29665493      0.03609734   0.0121802    0.80686791
  GOTERM_CC_DIRECT   GO:0005576\~extracellula r region                   7       0.10274475   0.00131741   NRTN, IL7, ADIPOQ, GDNF, FGFBP1, CCL27, TIMP1                                                                                                      40     407              12833       5.517874693      0.053863     0.01374662   1.21265635
  GOTERM_CC_DIRECT   GO:0005622\~intracellular                           6       0.08806693   0.03118422   VEGFB, CCL2, GFRAL, LGALS1, IFNG, GFRA2                                                                                                            40     586              12833       3.284897611      0.73567964   0.23365183   25.4130934
  GOTERM_CC_DIRECT   GO:0001772\~immunologi cal synapse                  2       0.02935564   0.07050482   ICAM1, LGALS3                                                                                                                                      40     24               12833       26.73541667      0.95361474   0.40058169   49.1690919
  GOTERM_CC_DIRECT   GO:0005604\~basement membrane                       2       0.02935564   0.08457142   TIMP3, TIMP1                                                                                                                                       40     29               12833       22.12586207      0.97555289   0.41149956   55.8597181
  **Day 14**                                                                                                                                                                                                                                                                                                                                 
  GOTERM_CC_DIRECT   GO:0005615\~extracellula r space                    21      0.48757836   2.2092E-15   CXCL1, CCL1, ICAM1, HAVCR1, CCL2, ICAM4, LGALS3, LGALS1, CXCL2, TIMP4, CCL5, TIMP2, TIMP3, IL22, CCL7, TIMP1, CCL12, CNTF, VEGFA, GFRA1, GFRA4     34     1316             18520       8.692115144      1.5099E-13   1.5099E-13   2.2871E-12
  GOTERM_CC_DIRECT   GO:0005578\~proteinaceo us extracellular matrix     6       0.1393081    7.9388E-05   LGALS3, LGALS1, TIMP4, TIMP2, TIMP3, TIMP1                                                                                                         34     253              18520       12.91792606      0.00538405   0.00269566   0.08164213
  GOTERM_CC_DIRECT   GO:0009986\~cell surface                            8       0.18574414   8.3982E-05   ICAM1, NOTCH2, NOTCH1, HAVCR1, LGALS3, LGALS1, VEGFA, TIMP2                                                                                        34     612              18520       7.120338331      0.00569472   0.00190185   0.0863644
  GOTERM_CC_DIRECT   GO:0005604\~basement membrane                       4       0.09287207   0.00059964   VEGFA, TIMP2, TIMP3, TIMP1                                                                                                                         34     93               18520       23.42820999      0.03996739   0.01014519   0.6151823
  GOTERM_CC_DIRECT   GO:0043235\~receptor complex                        4       0.09287207   0.00165145   NOTCH3, NOTCH2, NOTCH1, GFRA1                                                                                                                      34     132              18520       16.50623886      0.10630582   0.02222757   1.68599929
  GOTERM_CC_DIRECT   G0:0031012\~extracellula r matrix                   4       0.09287207   0.01026878   LGALS3, LGALS1, TIMP3, TIMP1                                                                                                                       34     254              18520       8.578045391      0.50435096   0.11039808   10.0744937
  GOTERM_CC_DIRECT   GO:0009897\~external side of plasma membrane        4       0.09287207   0.01174935   ICAM1, LGALS3, GFRA1, GFRA3                                                                                                                        34     267              18520       8.160387751      0.55232434   0.10846655   11.4488433
  GOTERM_CC_DIRECT   GO:0005886\~plasma membrane                         14      0.32505224   0.01438302   F11R, ICAM1, LGALS3, ICAM4, GFRAL, ICAM5, ICAM2, GAS1, NOTCH3, NOTCH2, NOTCH1, GFRA1, GFRA4, GFRA3                                                 34     3963             18520       1.924270087      0.62661575   0.11586313   13.8467933
  GOTERM_CC_DIRECT   GO:0005623\~cell                                    3       0.06965405   0.01898445   CXCL1, CCL12, CXCL2                                                                                                                                34     119              18520       13.73208107      0.72838062   0.13481944   17.8960826
  GOTERM_CC_DIRECT   GO:0005887\~integral component of plasma membrane   6       0.1393081    0.02446583   ICAM1, NOTCH2, ICAM4, ICAM5, ICAM2, TCAM1                                                                                                          34     942              18520       3.469464219      0.81443802   0.1550152    22.495014
  GOTERM_CC_DIRECT   GO:0070062\~extracellula r exosome                  10      0.23218017   0.03763242   ICAM1, F11R, LGALS3, ICAM2, LGALS1, GFRA1, GFRA4, TIMP2, TIMP3, TIMP1                                                                              34     2646             18520       2.058601218      0.92634761   0.21110903   32.6067177
  GOTERM_CC_DIRECT   GO:0001772\~immunologi cal synapse                  2       0.04643603   0.05888631   ICAM1, LGALS3                                                                                                                                      34     34               18520       32.04152249      0.98386897   0.29101261   46.440432
  GOTERM_CC_DIRECT   GO:0043025\~neuronal cell body                      4       0.09287207   0.07056971   CCL2, CNTF, GFRA1, TIMP2                                                                                                                           34     540              18520       4.034858388      0.99310167   0.31805473   52.8997324
  GOTERM_CC_DIRECT   GO:0031225\~anchored component of membrane          2       0.04643603   0.09356231   GFRA1, GFRA4                                                                                                                                       34     55               18520       19.80748663      0.99874403   0.37943918   63.5997306
  **Day 28**                                                                                                                                                                                                                                                                                                                                 
  GOTERM_CC_DIRECT   GO:0005615\~extracellula r space                    12      0.26298488   2.1928E-07   VEGFB, ICAM1, NRP1, CNTF, ICAM4, LGALS3, VEGFA, TIMP4, TIMP2, CCL5, TIMP3, TIMP1                                                                   29     814              13919       7.075658731      8.5518E-06   8.5518E-06   0.00019941
  GOTERM_CC_DIRECT   GO:0005578\~proteinaceo us extracellular matrix     4       0.08766163   0.00409476   TIMP4, TIMP2, TIMP3, TIMP1                                                                                                                         29     162              13919       11.85100043      0.14787636   0.07689457   3.6626419
  GOTERM_CC_DIRECT   GO:0043235\~receptor complex                        3       0.06574622   0.01401283   NOTCH3, NOTCH2, NOTCH1                                                                                                                             29     90               13919       15.99885057      0.42326116   0.16761087   12.0439761
  GOTERM_CC_DIRECT   GO:0005887\~integral component of plasma membrane   6       0.13149244   0.01431117   ICAM1, NOTCH2, ICAM4, ICAM5, ICAM2, JAG2                                                                                                           29     733              13919       3.928776403      0.43002802   0.13111284   12.2857025
  GOTERM_CC_DIRECT   GO:0005912\~adherens junction                       2       0.04383081   0.04336572   NOTCH1, JAG1                                                                                                                                       29     22               13919       43.63322884      0.82254361   0.2923503    33.1802839
  GOTERM_CC_DIRECT   GO:0001772\~immunologi cal synapse                  2       0.04383081   0.05677946   ICAM1, LGALS3                                                                                                                                      29     29               13919       33.10107015      0.89769033   0.31611022   41.2328984
  GOTERM_CC_DIRECT   GO:0005604\~basement membrane                       2       0.04383081   0.08676185   TIMP3, TIMP1                                                                                                                                       29     45               13919       21.33180077      0.97097463   0.3968896    56.1919967

The relationships between proteins and functional terms in the distal nerve stump following sciatic nerve transection {#sec2-10}
---------------------------------------------------------------------------------------------------------------------

The identified cytokines seem to affect many functional pathways and PPI networks via direct and indirect interactions. Therefore, to visualize smaller high-dimensional data subsets, the relationships between functional terms and differentially expressed proteins were assessed using the GOplot package in R (Walter et al., 2015) to integrate the expression data with the results of these analyses. Monocyte chemoattractant protein-1 (MCP-1/CCL2) regulated upon activation of normal T cell expressed and secreted (RANTES)/CCL5 and Galectin-3 that are related to monocyte and neutrophil chemotaxis, whereas CNTF and GDNF are specific to neuronal apoptotic processes. Notch1, Notch2, and Galectin-3 may participate in cell differentiation during nerve regeneration (**[Figure 5](#F5){ref-type="fig"}**). Additionally, inflammatory responses involve many cytokines, including CCL2, CCL17, CXCL2, CXCL9, CXCL11, CXCL13, NGFR, GDNF, IL10, IL20, and IL19 (**[Figure 5](#F5){ref-type="fig"}**).

![The relationship between the differentially expressed proteins and functional terms (biological processes and canonical pathways) in the distal nerve stump following sciatic nerve transection.\
Multiple biological processes and canonical pathways are labeled by different colors in circles on the right. The proteins linked to each term are listed in circles on the left.](NRR-15-503-g006){#F5}

Western blot verification of the protein array results in the distal nerve stump following sciatic nerve transection {#sec2-11}
--------------------------------------------------------------------------------------------------------------------

Western blot analysis was performed to validate the temporal expression patterns of the differentially expressed growth factors in the nerves identified in the microarray analyses. Western blot analysis confirmed that CNTF expression levels decreased markedly, whereas GDNF and HGF were increased after PNI (**Figure [6A](#F6){ref-type="fig"}** & **[B](#F6){ref-type="fig"}**), similar to the results of microarray analyses (**[Figure 6C](#F6){ref-type="fig"}**).

![Western blot analyses of the differentially expressed growth factors in the distal nerve stump following sciatic nerve transection.\
(A) Protein bands of HGF, CNTF and GDNF were measured by Western blot analysis. β-Actin was used as the reference protein. (B) Quantitative result of HGF, CNTF and GDNF expression. (C) The fold changes of HGF, CNTF and GFR alpha-1 were measured by protein microarray. Data represent the mean ± SEM (*n* = 4) from three independent experiments, statistically analyzed by one-way analysis of variance followed by Tukey's *post hoc* test. \**P* \< 0.05, \*\**P* \< 0.01, *vs*. control group (ctrl; 0 day after nerve injury). CNTF: Ciliary neurotrophic factor; GDNF: glial cell line-derived neurotrophic factor; HGF: hepatocyte growth factor.](NRR-15-503-g007){#F6}

Discussion {#sec1-4}
==========

Wallerian demyelination is the most typical cause of PNI, resulting in a series of complicated cellular responses and molecular mechanisms. Numerous studies have demonstrated that PNI induces cytokine production in immune and non-immune cells at sites distal to the nerve lesion (Karanth et al., 2006; Kiguchi et al., 2017). Such cytokines are closely related to Wallerian demyelination and participate in peripheral nerve regeneration (Rotshenker, 2011; He et al., 2016; Lin et al., 2019). In the current study protein microarray and bioinformatic analyses were performed to examine the detailed kinetic changes in cytokine production in distal nerve stumps following sciatic nerve injury.

In this study, the 67 cytokines on the protein microarray comprise growth factors, chemotaxis factors, and other proteins. By screening differentially expressed cytokines after PNI, we discovered that some growth factors may be critical for sciatic nerve injury and regeneration. For instance, previous studies reported that GFR alpha-1 is expressed in myelinated peripheral nerves and the neuromuscular junction, exerting its effects on motor neurons by interacting with GDNF (Hase et al., 1999; Rosich et al., 2017). In line with previous findings, we detected upregulation of GFR alpha-1 protein at 7, 14, and 28 days after PNI. Additionally, HGF also increased 1.5-fold at 28 days post injury. HGF has been shown to promote the migration and proliferation of Schwann cells and increase the expression of neurotrophic factors and inflammatory cytokines such as GDNF and tumor necrosis factor-α (Ko et al., 2018). In contrast, we found that CNTF was downregulated over most of the post-injury period studied. The PPI network suggested that CNTF regulates neuronal apoptosis via the JAK/STAT signaling pathway. All of these results highlight the central roles of growth factors in nerve regeneration.

Chemokine factors have been identified as important modulators of peripheral nerve regeneration (Taskinen and Röyttä, 2000). MCP-1/CCL2, a CCL family member, is expressed at low levels under basal conditions and is upregulated rapidly and markedly in Schwann cells and neurons (Schreiber et al., 2001; Tanaka et al., 2004; Niemi et al., 2013). In this study, we found that MCP-1 expression increased 10-fold from 1 to 28 days after sciatic nerve injury. Consequently, the injury-induced increase in MCP-1 may lead to recruitment of inflammatory monocytes and macrophages to nerves via the Toll-like receptor-4 or STAT3-dependent signaling pathways (Niemi et al., 2013). Moreover, other CCL family members, including RANTES/CCL5, cutaneous T-cell-attracting chemokine (CTACK)/CCL27 were also upregulated at different time points after PNI. RANTES/CCL5 is another important chemokine that exhibits strong chemoattractant activity towards monocytes and leukocytes, inducing immune cell migration and protection of neurons, either directly or indirectly (Raport et al., 1996; Tillie-Leblond et al., 2000; Tokami et al., 2013; Solga et al., 2015). CTACK was reported to accelerate skin regeneration via specific chemokine-receptor interactions (Inokuma et al., 2006), suggesting an important role of CTACK in nerve regeneration.

Notch proteins (Notch-1--4) are transmembrane receptors that regulate cellular processes, including cell proliferation, apoptosis, and angiogenesis (Bolós et al., 2007; Fortini, 2009; Kopan and Ilagan, 2009). During nerve regeneration, notch signaling mediates the differentiation of adipose-derived stem cells into Schwann-like cells and of monocytes into macrophages (Ohishi et al., 2001; Kingham et al., 2009). In our study, both Notch-1 and -2 were upregulated and may play important roles in the differentiation of the nervous system. It is also worth noting that Neuropilin-1 was upregulated from 1 to 28 days and Neuropilin-2 within 7 days after PNI. These proteins are closely related to axonal guidance, angiogenesis, and motor neuron migration. Triggering receptor expressed on myeloid cells 1 (TREM1) is another protein involved in immune response signaling pathways (Collins et al., 2009; Kingham et al., 2009) and activation of TREM1 may increase the secretion of pro-inflammatory cytokines (Walter, 2016). TREM1 continually increased over the time period we examined and was related to neutrophil chemotaxis. These results suggest that a cytokine network is involved in the kinetics of macrophage recruitment and nerve removal of damaged nerves.

Bioinformatic analyses are efficient methods for interpreting proteomic or genomic information. PPI network bioinformatic data are used to predict protein functionality within sequence homology clusters (Athanasios et al., 2017). Chemotactic factors, immune factors, and other cytokines were identified in our PPI network. Thymus and activation-regulated chemokine (TARC)/CCL17 accelerates fibroblast migration and wound healing (Kato et al., 2011). Rac GTPase, together with mammalian T-cell lymphoma invasion, metastasis factor 1 (TIAM-1) and CDC42, has been shown to mediate axon guidance (Demarco et al., 2012). These proteins may participate in nerve regeneration directly or indirectly. Additionally, the KEGG pathways resulted in the cytokine-cytokine receptor interactions keeping active during Wallerian degeneration. Other enriched pathways included the JAK/STAT, PI3K/Akt, and chemokine signaling pathways. Furthermore, our study demonstrated a diverse array of biological processes, including chemotaxis, inflammatory and immune responses, cell migration, cell proliferation, apoptosis, and angiogenesis, that were significantly activated in the distal nerve stump following sciatic nerve transection. Based on the relationships between cytokines and our bioinformatic data, further in-depth studies are needed to determine the detailed mechanism of peripheral nerve regeneration.

In summary, we analyzed global changes in cytokine expression patterns at the distal nerve stump following PNI using protein microarray analysis. Although our results did not elucidate the mechanism of PNI, bioinformatic analysis enabled us to gain a comprehensive view of cytokine expression changes with time. They also show the relationships of these cytokines with canonical pathways, biological functions, and networks during Wallerian degeneration. Overall, our study may help identify the potential clinic treatments for PNI.

Additional files:
=================

**[Additional Table 1](#T2){ref-type="table"}:** *All canonical pathways and involved molecules at 1, 7, 14, and 28 days after sciatic nerve injury.*

***Additional Table 2:*** *All biological function categories and involved molecules at 1, 7, 14, and 28 days after sciatic nerve injury.*

***[Additional Table 3](#T3){ref-type="table"}:*** *All cellular component categories and involved molecules at 1, 7, 14, and 28 days after sciatic nerve injury.*
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